Orthopaedic & Rheumatologic Institute Outcomes
Percentage of Newly Diagnosed Patients with Psoriatic Arthritis Starting Biologic DMARDs who had Tuberculosis Testing (2015-2019)
Percentage of Newly Diagnosed Patients with Psoriatic Arthritis Starting Biologic DMARDs who had Tuberculosis Testing (N=480)
DMARDs = disease-modifying antirheumatic drugs
- Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, Moreland LW, O’Dell J, Winthrop KL, Beukelman T, Bridges SL Jr, Chatham WW, Paulus HE, Suarez-Almazor M, Bombardier C, Dougados M, Khanna D, King CM, Leong AL, Matteson EL, Schousboe JT, Moynihan E, Kolba KS, Jain A, Volkmann ER, Agrawal H, Bae S, Mudano AS, Patkar NM, Saag KG. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res. 2012 May;64(5):625-639.